NMPA Medical Device Classification: Questions to Resolve Before China Registration

Why NMPA medical device classification comes first

China currently manages Class I devices through filing and Class II and Class III devices through registration. For imported devices, the NMPA is responsible for imported Class I filing and imported Class II and III registration review. The device-specific result still requires formal confirmation.

Build the classification input file

• Intended purpose and target population
• Operating principle and key technology
• Structure, components and accessories
• Contact type, duration and invasiveness
• Software, energy source and combination-product questions
• Comparable products and proposed China claims

Do not transpose another market’s class

FDA, EU MDR and other jurisdictions use their own systems. Existing approvals are important evidence, but the class assigned elsewhere does not automatically determine the China class.

Connect classification to the commercial decision

Classification affects the likely registration route, evidence plan, local resources and launch sequence. Commercial forecasting should use a confirmed pathway rather than a generic timeline copied from another device.